about
Targeted therapies in sarcomas: challenging the challengeCaveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathwayCaveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth.EphA2-induced angiogenesis in ewing sarcoma cells works through bFGF production and is dependent on caveolin-1.Caveolin-1 modulates the ability of Ewing's sarcoma to metastasize.Caveolin-1 in sarcomas: friend or foe?Prospects for MEK inhibitors for treating cancer.The importance of being dead: cell death mechanisms assessment in anti-sarcoma therapy.DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1.High-resolution circuit for the diagnosis of faecal incontinence. Patient satisfaction.2-deoxyglucose induces Noxa-dependent apoptosis in alveolar rhabdomyosarcoma.The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis.Sacral neuromodulation in patients with congenital faecal incontinence. Special issues and review of the literature.Treatment of chronic anal fissure with sacral neuromodulation: a pilot study.EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma.Sacral neuromodulation in a patient with faecal incontinence and unknown sacral partial agenesis.
P50
Q21285014-F6672BA2-7CEE-4C9D-9B67-F2B4D25DF23DQ28816968-367E6C0B-4FBA-436E-9439-D0AC35F07BDDQ34654615-877EB7E2-3C3A-4870-8E3D-632B23030275Q34949575-2411066F-69C2-425B-9039-DA9FC14FCB08Q36921347-0A285F06-7981-4E55-929C-3F368471CBDAQ37862525-3C0577E7-9D49-4452-8022-B7AE3C2C856EQ38193520-7BF2E91F-9A86-408B-8A65-923E2FEACA23Q38437281-47D28569-ABCE-478E-A6C0-52DE64BE3B49Q38439891-E0F11966-BB47-427C-A777-B26A72106800Q38731762-0DCB83A6-C893-44A0-8BCF-E3E5A51A3D36Q39475175-365E8E78-4A7D-4034-B6A0-CAA088BEBFC8Q39801979-76059FD0-D292-47FB-BEC9-49B61ECC19A4Q48230210-4D774D77-0935-4921-A14E-DE81B3C0143DQ50169452-53FD26C9-EAD9-4A5B-95DC-21F1F718345DQ53824877-767C097B-DD66-4A71-BDB4-026D5C00C410Q53841467-7F4809B7-A653-4803-9C90-98AD94D31FAB
P50
description
onderzoeker
@nl
researcher ORCID id 0000-0002-5290-3346
@en
name
Laura Lagares-Tena
@ast
Laura Lagares-Tena
@en
Laura Lagares-Tena
@es
Laura Lagares-Tena
@nl
type
label
Laura Lagares-Tena
@ast
Laura Lagares-Tena
@en
Laura Lagares-Tena
@es
Laura Lagares-Tena
@nl
prefLabel
Laura Lagares-Tena
@ast
Laura Lagares-Tena
@en
Laura Lagares-Tena
@es
Laura Lagares-Tena
@nl
P106
P21
P31
P496
0000-0002-5290-3346